Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

New nanocarriers improve drug delivery for disease treatment.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Keratin protein production in cells is controlled by a complex system that changes with cell type, health, and conditions like injury or cancer.

Tadalafil and Finasteride may help treat aggressive melanoma.

Collagen makes skin stiff, and preservation methods greatly increase tissue stiffness.

Targeting lipid metabolism can help treat advanced, resistant cancers.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Essential oils from Curcuma species, like turmeric, have compounds that can fight inflammation, cancer, and bacteria, and can also stimulate hair regrowth in bald males.

Different fibroblasts play key roles in skin healing and scarring.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

New therapies are being developed that target integrin pathways to treat various diseases.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Horse skin stem cells combined with platelet-rich plasma improve skin healing.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.